EFDID: 369195EFD: View Filing

Issuer: Nacuity Pharmaceuticals, Inc. (0001690279) - D/A

Accession: 0001690279-22-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001690279
  • Entity Name:
    Nacuity Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    FORT WORTH CLUB BLDG.
    306 W. 7TH STREET, SUITE 310
    FORT WORTH, TX 76102
  • Persons:
    Related Persons 7
    Halden Conner
    Executive Officer, Director 
    President and Chief Executive Officer
    David Wohlberg
    Executive Officer, Director 
    Secretary
    Gerald Cagle
    Director
    Robin Steel
    Director
    Benjamin Yerxa
    Director
    Charles Lieser
    Executive Officer 
    Chief Financial Officer
    Robert Ruffolo
    Director
EDGAR: Offering Information
  • Accession Date:
    01/03/2022
  • First Sale Date:
    03/16/2021
  • Offering Amount:
    $17,400,000
  • Amount Sold:
    $11,626,000
  • Amount Remaining:
    $5,774,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Units comprised of Convertible Preferred Shares plus Common Stock Purchase Warrants; Common Stock issued for Warrant conversion; Convertible Preferred Shares issued for exchange of Common Stock
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, CT, IA, ID, IN, KS, KY, MA, MD, MI, MN, MO, NH, NJ, NM, OH, PA, TX, VA, WI
Inactive:CO, GA, IL, MT, NV, NY, SC, WA
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Maxim Group LLC 120708 Clifford Adam Teller 4631188 All States
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Nacuity Pharmaceuticals, Inc./s/ Halden ConnerHalden ConnerPresident and Chief Executive Officer2022-01-03
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Jan. 03, 2022 369195: 0001690279-22-000001 Nacuity Pharmaceuticals, Inc.
Offer Amount: $17,400,000
Amount Sold: $11,626,000
Remaining: $5,774,000
D Mar. 30, 2021 369195: 0001690279-21-000003 Nacuity Pharmaceuticals, Inc.
Offer Amount: $11,000,000
Amount Sold: $3,171,000
Remaining: $7,829,000